StonvexLoading…
StonvexStonvexStonvexCore line items from FMC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $758.60M | $3.47B | $542.20M | $1.05B |
Operating Income | $-81.00M | $-1.63B | $-396.30M | $126.40M |
Net Income | $-281.30M | $-2.24B | $-569.30M | $66.70M |
EPS (Diluted) | $-2.25 | $-17.88 | $-4.52 | $0.53 |
Total Assets | $9.42B | $9.69B | $12.08B | $12.30B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $390.90M | $584.50M | $497.70M | $438.20M |
Free Cash Flow OCF − CapEx | $-617.50M | $-102.50M | $-733.60M | $-525.70M |
Shares Outstanding | 125.28M | 125.16M | 125.20M | 125.60M |